{"ticker": {"uuid": "22007311-0efb-49ca-af11-1bba60413c2f", "symbol": "3933", "name": "The United Laboratories International Holdings Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPMW5rS09CdUNqdHZocjRYWDYtaUpPU2dOYXpqcXNIUXN1M1VhUWJUQnp0R0hLWHp6cU92eTVyMTYycW82LXlRcE9MN196b3g1aDFqMkhFZUNfTW9xOGNDdHV3eFZTcVh1dHZzZ0xUWjlIQ0M5Q1dsSUxNcUhhdkE4WGp2dVVhNzJHU2FvLWV1cjk3aGFKZjdvRjktY3MtOUpLYnhKek5IbDRHbnB4Mm9STFVyMmlqRm10TDJlZWhOVFM5dFlh?oc=5", "source_name": "TipRanks", "published_at": "2026-07-16T04:28:47+00:00", "published_display": "16 Jul 2026 04:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Laboratories Confirms 2025 Final Dividend and Payment Timetable", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNaFVQRUlfNzRaVldjYkFCUGpnem9QT2JHczJXcWwtVVNEVk5oZTlHZTZ3eEVPdHRMZGlQZmxldDN0VF9qWHFEZzNUMmpLSEpWZW9IOTBCaFFCcy1zRE5TRFBjMXFDN2RkTGRIeGVYanlHVlFGZUJ2VUc1TllRODk4THpHS0pIQkEzbzV0Yzh2cktraHhOVjVZbUlYckVNazJkWmw1S1VwSHJSdXlpVGQtNzdHYnJoWUJNQjdxR0thZE1rcmtKYWl5Z0VYdlhaemstYW1jcG4yeVFSeWtNV2hqZHJRRGM0Zw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Laboratories International Holdings (SEHK:3933) Valuation After Positive UBT251 Phase 2 Diabetes Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNV2I4aVVvN3pkVER6UFF6TmV4UEVYNHB3LTlnNnk5OHFaMTEtek9VWF9SZGJ5aXNsYVo4NUxYWWRVZ2ZDQ0dkbmZPb2ZWbnM4a2drQ2JMdnhkX3hSZE5UOGNJZXN5UGNoSjlXRE4td3VVMF9jUnJQbXFBRURDTEJneWxRNWItZGNmb3gxSjdTVFZvcXpzamlUaTRSM0lEY21zYlQ5RFk2MzVidFVnTm5Cc2plbUpmRHc?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPY3lZYS11TkYxQ1RUbE9OaXJzT1NaYXR0OWtBdTFlbW94Ujd1QjRNamlfTWNzeld6cWY5U3lid1kzaTJIOUNYNlotcl9TZzdRcVhjRFNvSTRrYTN2OVkxdU5rVVZ1ajdUV0drdkQ4SkJ6Mi0wbVRleWQ0NzJsejc1LVdReTNjM0xVbWxyZXhsY25tRlV3S0hOZ1lyazFrREhNSXBPWTNWWmxHRkwwa1lHckt6TFJhb3NCWkh0NGNPSWNSVkRrUUhfUFRnZUNLeTlMd2VHZWg2Ul9uaUZ6SG5R?oc=5", "source_name": "Reuters", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPVk1BVzRfd0pEM05rLU9WSHpja2NNSVhjOFF1Y2p5TExTdDY0Q3ROZTFGemtDd0hsNDM3YzdPX3JRZEUwYmJZekRVOS1XaTZpMGx1aHdfR19JRWRGN3NHSDlFbm1Ndkk1RWtLLUJIUkk3bEwzbGVCQThFeUt2WVNWeUY1MzNJeHYyaE1LVEpHSzktMUo1X195SUlpUmxMTVhacDBCVkRJZER1Q283VVRuVmRfb1Q0dw?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-03-25T07:00:00+00:00", "published_display": "25 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FAST NEWS: United Lab sinks after top shareholder sells down stake at discount", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObkpQbmdBS2xZM2RaY3dhRGxPSVRfNmFqR3JOXzJLZEQ5Q0NkeFlEcjR2dGkwSmt6VTVTZWE1R1lyZUYtMnpVTWJOaW1DOF96dXlxaDBFdzl5dzJDdDdrOVhweHdub0g4RDIxaUx6S3NVX2ZFVXQwNUhPSE9kT2k3bjV3N0pDWVl6YzY2TE9wVEQwTjBqeFJMakZrbzVSM2dTaU51VmRWenc?oc=5", "source_name": "thebambooworks.com", "published_at": "2023-09-19T07:00:00+00:00", "published_display": "19 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPMW5rS09CdUNqdHZocjRYWDYtaUpPU2dOYXpqcXNIUXN1M1VhUWJUQnp0R0hLWHp6cU92eTVyMTYycW82LXlRcE9MN196b3g1aDFqMkhFZUNfTW9xOGNDdHV3eFZTcVh1dHZzZ0xUWjlIQ0M5Q1dsSUxNcUhhdkE4WGp2dVVhNzJHU2FvLWV1cjk3aGFKZjdvRjktY3MtOUpLYnhKek5IbDRHbnB4Mm9STFVyMmlqRm10TDJlZWhOVFM5dFlh?oc=5", "source_name": "TipRanks", "published_at": "2026-07-16T04:28:47+00:00", "published_display": "16 Jul 2026 04:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Laboratories Confirms 2025 Final Dividend and Payment Timetable", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNaFVQRUlfNzRaVldjYkFCUGpnem9QT2JHczJXcWwtVVNEVk5oZTlHZTZ3eEVPdHRMZGlQZmxldDN0VF9qWHFEZzNUMmpLSEpWZW9IOTBCaFFCcy1zRE5TRFBjMXFDN2RkTGRIeGVYanlHVlFGZUJ2VUc1TllRODk4THpHS0pIQkEzbzV0Yzh2cktraHhOVjVZbUlYckVNazJkWmw1S1VwSHJSdXlpVGQtNzdHYnJoWUJNQjdxR0thZE1rcmtKYWl5Z0VYdlhaemstYW1jcG4yeVFSeWtNV2hqZHJRRGM0Zw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United Laboratories International Holdings (SEHK:3933) Valuation After Positive UBT251 Phase 2 Diabetes Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNV2I4aVVvN3pkVER6UFF6TmV4UEVYNHB3LTlnNnk5OHFaMTEtek9VWF9SZGJ5aXNsYVo4NUxYWWRVZ2ZDQ0dkbmZPb2ZWbnM4a2drQ2JMdnhkX3hSZE5UOGNJZXN5UGNoSjlXRE4td3VVMF9jUnJQbXFBRURDTEJneWxRNWItZGNmb3gxSjdTVFZvcXpzamlUaTRSM0lEY21zYlQ5RFk2MzVidFVnTm5Cc2plbUpmRHc?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPY3lZYS11TkYxQ1RUbE9OaXJzT1NaYXR0OWtBdTFlbW94Ujd1QjRNamlfTWNzeld6cWY5U3lid1kzaTJIOUNYNlotcl9TZzdRcVhjRFNvSTRrYTN2OVkxdU5rVVZ1ajdUV0drdkQ4SkJ6Mi0wbVRleWQ0NzJsejc1LVdReTNjM0xVbWxyZXhsY25tRlV3S0hOZ1lyazFrREhNSXBPWTNWWmxHRkwwa1lHckt6TFJhb3NCWkh0NGNPSWNSVkRrUUhfUFRnZUNLeTlMd2VHZWg2Ul9uaUZ6SG5R?oc=5", "source_name": "Reuters", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPVk1BVzRfd0pEM05rLU9WSHpja2NNSVhjOFF1Y2p5TExTdDY0Q3ROZTFGemtDd0hsNDM3YzdPX3JRZEUwYmJZekRVOS1XaTZpMGx1aHdfR19JRWRGN3NHSDlFbm1Ndkk1RWtLLUJIUkk3bEwzbGVCQThFeUt2WVNWeUY1MzNJeHYyaE1LVEpHSzktMUo1X195SUlpUmxMTVhacDBCVkRJZER1Q283VVRuVmRfb1Q0dw?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-03-25T07:00:00+00:00", "published_display": "25 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FAST NEWS: United Lab sinks after top shareholder sells down stake at discount", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObkpQbmdBS2xZM2RaY3dhRGxPSVRfNmFqR3JOXzJLZEQ5Q0NkeFlEcjR2dGkwSmt6VTVTZWE1R1lyZUYtMnpVTWJOaW1DOF96dXlxaDBFdzl5dzJDdDdrOVhweHdub0g4RDIxaUx6S3NVX2ZFVXQwNUhPSE9kT2k3bjV3N0pDWVl6YzY2TE9wVEQwTjBqeFJMakZrbzVSM2dTaU51VmRWenc?oc=5", "source_name": "thebambooworks.com", "published_at": "2023-09-19T07:00:00+00:00", "published_display": "19 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 66, "total_relevant": 6, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 4, "score": 49, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 69, "events": [{"event": "general", "label": "Market update", "weight": 2.0, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 9.13, "latest_week": "2026-07-10", "one_week_move": 0.6, "four_week_move": 7.5, "twelve_week_move": -9.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.494038, "market_dynamics_buy_signal": false, "relative_strength": -19.9437, "fair_value_gap": -10.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.9145, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.6% over one week, +7.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 45, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Pharmaceutical Executive", "count": 1}, {"label": "thebambooworks.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Capital return", "count": 1}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "69/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.6% over one week, +7.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251"}], "updated_at": "2026-07-17T18:58:38.799235+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}